SummaryResearchers at the the Indiana University School of Medicine have found that removing or reducing a specific brain cell enzyme, known as IDOL, can significantly lower the buildup of amyloid plaques while also helping the brain resist further damage. As of now, Lecanemab and Donanemab drugs can help achieve this